Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02724033Phase 4Terminated
Phase 4, randomised trial of bupivacaine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Indiana University. Primary endpoint: Evidence of Post Operative Nausea and Vomiting at 24 hours. Started May 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02724033.